Histogen Announces Filing an Investigational New Drug Application for HST-003
PharmaEngine, Inc. and Sentinel Oncology Limited Enter into an Exclusive Collaboration and License Agreement for SOL-578, a Chk1 inhibitor
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars Korean Securities Dealers Automated Quotations:226950.KQ
Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020
- Advertisement -